🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard M. Sherry

University of Hertfordshire

ORCID: 0000-0001-7580-3228

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia..

4 citations

Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre +3 more

111 citations

Richard M. Sherry, James Chih‐Hsin Yang, Paul F. Robbins, Mackenzie L. Shindorf, Amy R. Copeland +10 more

176 citations

Nolan R. Vale, Nikolaos Zacharakis, Sri Krishna, Zhiya Yu, Billel Gasmi +33 more

0 citations

James C. Yang, Richard M. Sherry, Marybeth S. Hughes, Udai S. Kammula, Donald E. White +4 more